Angina is a type of chest discomfort or pain due to poor blood flow through the blood vessels (coronary vessels) of the heart muscle (myocardium).
There are different types of angina:
Get medical help right away if you have new, unexplained chest pain or pressure. If you have had angina before, call your health care provider.
Jeffrey Moses is an Interventional Cardiologist and a Cardiologist in New York, New York. Moses has been practicing medicine for over 49 years and is rated as an Elite expert by MediFind in the treatment of Angina. He is also highly rated in 19 other conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Percutaneous Coronary Intervention (PCI), and Atherectomy. Moses is currently accepting new patients.
Erik Ohman is an Interventional Cardiologist and a Cardiologist in Durham, North Carolina. Ohman has been practicing medicine for over 42 years and is rated as an Elite expert by MediFind in the treatment of Angina. He is also highly rated in 23 other conditions, according to our data. His top areas of expertise are Acute Coronary Syndrome, Heart Attack, Angina, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG). Ohman is currently accepting new patients.
John Spertus is a Cardiologist in Kansas City, Missouri. Spertus has been practicing medicine for over 34 years and is rated as an Elite expert by MediFind in the treatment of Angina. He is also highly rated in 28 other conditions, according to our data. His top areas of expertise are Angina, Heart Attack, Heart Failure, Percutaneous Coronary Intervention (PCI), and Angioplasty. Spertus is currently accepting new patients.
Summary: Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting trial (TOP-CABG trial) is a multicenter, randomized, double-blind, non-inferiority, parallel controlled trial. The aim of TOP-CABG is to investigate whether de-escalated dual antiplatelet therapy (De-DAPT) is non-inferior to dual antiplatelet therapy (DAPT) in efficacy on inhibiting great saphenous ve...
Summary: The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.
Published Date: February 23, 2022
Published By: Thomas S. Metkus, MD, Assistant Professor of Medicine and Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Boden WE. Angina pectoris and stable ischemic heart disease. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 62.
Bonaca MP, Sabatine MS. Approach to the patient with chest pain. In: Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Philadelphia, PA: Elsevier; 2022:chap 35.
Lange RA, Mukherjee D. Acute coronary syndrome: unstable angina and non-ST elevation myocardial infarction. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 63.
Morrow DA, de Lemos J. Stable ischemic heart disease. In: Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Philadelphia, PA: Elsevier; 2022:chap 40.